RT Journal Article
SR Electronic
T1 Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003388
DO 10.1136/jitc-2021-003388
VO 9
IS 11
A1 Conlon, Kevin
A1 Watson, Dionysios C
A1 Waldmann, Thomas A
A1 Valentin, Antonio
A1 Bergamaschi, Cristina
A1 Felber, Barbara K
A1 Peer, Cody J
A1 Figg, William D
A1 Potter, E Lake
A1 Roederer, Mario
A1 McNeel, Douglas G
A1 Thompson, John A
A1 Gupta, Sumati
A1 Leidner, Rom
A1 Wang-Gillam, Andrea
A1 Parikh, Nehal S
A1 Long, Debby
A1 Kurtulus, Sema
A1 Ho Lee, Lang
A1 Chowdhury, Niladri Roy
A1 Bender, Florent
A1 Pavlakis, George N
YR 2021
UL http://jitc.bmj.com/content/9/11/e003388.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.